The global epidemiology of coronavirus disease 2019 (COVID-19) suggests a wide
spectrum of clinical severity, ranging from asymptomatic to fatal. Although the clinical and …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus
disease 2019 (COVID-19), has currently infected over 6.5 million people worldwide. In …

We performed RNA-seq and high-resolution mass spectrometry on 128 blood samples from
COVID-19-positive and COVID-19-negative patients with diverse disease severities and …

Background: The present study aimed to determine the global prevalence of anosmia and
dysgeusia in coronavirus disease 2019 (COVID-19) patients and to assess their association …

Patients with coronavirus disease 2019 (COVID-19) may have symptoms of anosmia or
partial loss of the sense of smell, often accompanied by changes in taste. We report 5 cases …

Abstract Coronavirus disease 2019 (COVID-19) pandemic began in China with a group of
severe pneumonia cases, later identified to be caused by the severe acute respiratory …

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the
agent of novel coronavirus 2019 (COVID‐19), has kept the globe in disquiets due to its …

Background: The coronavirus disease 2019 (COVID-19) pandemic has been associated
with a dramatic increase in postviral olfactory dysfunction (PVOD) among patients who are …

Introduction A rapidly evolving evidence suggests that smell dysfunction is a common
symptom in COVID-19 infection with paucity of data on its duration and recovery rate …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a newly emerged
coronavirus, has sparked a global pandemic with its airborne transmission and ability to …